Key result
Progressive reduction of dialysate sodium with Diacontrol showed no short-term clinical advantage over standard dialysis, with higher post-dialysis plasma conductivity (13.5 vs 13.4 mS/cm; P<0.001).
Why the study?
Does progressive reduction of dialysate sodium with Diacontrol improve clinical parameters compared to fixed dialysate conductivity in stable dialysis patients?
RCT (n=10)
Crossover
Does progressive reduction of dialysate sodium with Diacontrol improve clinical parameters compared to fixed dialysate conductivity in stable dialysis patients?
Absolute Event Rate: 13.5% vs 13.4%
p-value: p=<0.001
In stable dialysis patients, progressive reduction of dialysate sodium with Diacontrol did not offer short-term clinical advantages over standard fixed dialysate conductivity.
We examined whether progressive reduction of dialysate sodium with Diacontrol (DC, plasma conductivity targeted feedback system) confers any clinical benefit over a similar strategy using dialysis with fixed dialysate conductivity (HD). Ten stable patients entered a randomized crossover study conducted over 360 dialysis sessions. Sodium balance, blood pressure (BP), intradialytic hypotension rates (IDH), thirst score, and extracellular water (ECW) were recorded. Interdialytic ambulatory BP was measured at the highest and lowest conductivities. BP, interdialytic weight gains and thirst scores were low at the outset and were not altered significantly by conductivity reduction. The lowest fixed dialysate setting of 13.2 mS/cm resulted in greater sodium depuration than the lowest conductivity setting allowable with DC, as reflected by lower post dialysis plasma conductivity (13.4 +/- 0.14 mS/cm versus 13.5 +/- 0.04 mS/cm, p < 0.001). Predialysis ECW fell from 0.22 +/- 0.04 l/kg to 0.21 +/- 0.09 l/kg as conductivity reduced with HD (p < 0.05), but did not change significantly with DC. When HD and DC were matched for end-dialysis plasma conductivity, there were no differences in BP, IDH frequency, or dialysis tolerability even at the lowest conductivity settings. In a setting of dialysate sodium reduction, DC did not appear to have any short-term clinical advantage over standard dialysis, and its range is limited at the lower conductivity settings.
No takes yet. Share an insight, caveat, or question.
Selby et al. (2007) conducted an RCT in End-stage renal disease on dialysis (n=10). Progressive reduction of dialysate sodium with Diacontrol (DC) vs. Dialysis with fixed dialysate conductivity (HD) was evaluated on Post-dialysis plasma conductivity at lowest setting (mS/cm) (p=<0.001). Progressive reduction of dialysate sodium with Diacontrol showed no short-term clinical advantage over standard dialysis, with higher post-dialysis plasma conductivity (13.5 vs 13.4 mS/cm; P<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: